Sevens Report Co-editor Tyler Richey Quoted in MarketWatch on July 10, 2020

Tyler Richey, co-editor of Sevens Report Research, said oil prices did get a boost after Gilead Sciences Inc. GILD, 1.97% said clinical trial data show its antiviral drug remdesivir reduced the risk of death for coronavirus patients by 62%. The news also provided support to the U.S. stock market. “Oil futures have been trading with a high degree of correlation…” said Richey. Click here to read the full article.